Abstract:Gene delivery to the posterior segment of the eye is severely hindered by the impermeability of defensive barriers; therefore, in clinical settings, genomic medicines are mainly administered by intravitreal injection. We previously found that penetratin could transport the covalently conjugated fluorophore to the fundus oculi by topical instillation. In this study, gene delivery systems enabled by penetratin were designed based on electrostatic binding to target the retina via a noninvasive administration route and prepared with red fluorescent protein plasmid (pRFP) and/or poly(amidoamine) dendrimer of low molecular weight (G3 PAMAM). Formulation optimization, structure confirmation, and characterization were subsequently conducted. Penetratin alone showed limited ability to condense the plasmid but had powerful uptake and transfection by corneal and conjunctival cells. G3 PAMAM was nontoxic to the ocular cells, and when introduced into the penetratin-incorporated complex, the plasmid was condensed more compactly. Therefore, further improved cellular uptake and transfection were observed. After being instilled in the conjunctival sac of rats, the intact complexes penetrated rapidly from the ocular surface into the fundus and resided in the retina for more than 8 h, which resulted in efficient expression of RFP in the posterior segment. Intraocular distribution of the complexes suggested that the plasmids were absorbed into the eyes through a noncorneal pathway during which penetratin played a crucial role. This study provides a facile and friendly approach for intraocular gene delivery and is an important step toward the development of noninvasive gene therapy for posterior segment diseases.

Intraocular Sirna Delivery Mediated by Penetratin Derivative to Silence Orthotopic Retinoblastoma Gene

Noninvasive Delivery of Oligonucleotide by Penetratin-Modified Polyplexes to Inhibit Protein Expression of Intraocular Tumor

Single intravitreal administration of a tetravalent siRNA exhibits robust and efficient gene silencing in rodent and swine photoreceptors

Single intravitreal administration of a tetravalent siRNA exhibits robust and efficient gene silencing in mouse and pig photoreceptors

Octopus-like Flexible Vector for Noninvasive Intraocular Delivery of Short Interfering Nucleic Acids.

Facile Noninvasive Retinal Gene Delivery Enabled by Penetratin.

pH-Responsive polymer boosts cytosolic siRNA release for retinal neovascularization therapy

Combined Ultrasound-Targeted Microbubble Destruction and Polyethylenimine-Mediated Plasmid Dna Delivery to the Rat Retina: Enhanced Efficiency and Accelerated Expression

In Vitro and in Vivo Therapeutic Sirna Delivery Induced by a Tryptophan-Rich Endosomolytic Peptide

Camouflage Nanoparticles Enable in Situ Bioluminescence-Driven Optogenetic Therapy of Retinoblastoma

Reduction-responsive Polymeric Micelles for Trans-Corneal Targeted Delivery of Microrna-21-5p and Glaucoma-Specific Gene Therapy.

Long-term RNA Interference Gene Therapy in a Dominant Retinitis Pigmentosa Mouse Model

Effective intravitreal gene delivery to retinal pigment epithelium with hyaluronic acid nanospheres

The Potential Therapeutic of Sirna Eye Drops in Ocular Diseases

Intraocular Mrna Delivery with Endogenous MmPEG10-based Virus-Like Particles

Mesoporous Silica-Based Nanoparticles as Non-Viral Gene Delivery Platform for Treating Retinitis Pigmentosa

Boosting RNAi Therapy for Orthotopic Glioblastoma with Nontoxic Brain-Targeting Chimaeric Polymersomes

Lipid nanoparticle technology-mediated therapeutic gene manipulation in the eyes

Delivery of cationic polymer-siRNA nanoparticles for gene therapies in neural regeneration.

Periocular Gene Transfer of Pigment Epithelium-Derived Factor Inhibits Choroidal Neovascularization in a Human-Sized Eye

Novel Hydrophobically Modified Asymmetric Rnai Compounds (Sd-Rxrna) Demonstrate Robust Efficacy in the Eye